DaVita laying off 109 at Orlando facility after selling prescription unit

Walgreens has said it will acquire DaVita's DaVita Rx prescription-drug unit. Terms of the deal were not announced. Following the sale, DaVita has announced that more than 100 jobs will be cut at a prescription-drug distribution facility in Orlando.

Walgreens has said it will acquire DaVita's DaVita Rx prescription-drug unit. Terms of the deal were not announced. Following the sale, DaVita has announced that more than 100 jobs will be cut at a prescription-drug distribution facility in Orlando. At the facility, employees packaged prescription drugs to be distributed to patients undergoing dialysis. A Walgreens spokesperson noted, "On July 25, we reached an agreement with DaVita Rx, a pharmacy owned by DaVita Inc. to service patients with kidney disease, to purchase DaVita's non-dialysis related prescription files that are billed as a pharmacy benefit, mostly under Medicare Part D. This prescription file-transfer sale is anticipated to close in September and when the anticipated deal closes, patients who use DaVita Rx's pharmacy mail services will have the opportunity to transition to become Walgreens retail pharmacy patients." In addition, DaVita employees will "have the opportunity to interview for open positions at existing Walgreens retail stores and central facility location," Walgreens said.